Abstract:Objective:To observe the expression of Galectin-1 in human ectopic endometrial cells with different receptivity and its role in the process of embryo implantation.Methods:The expression and localization of Galectin-1 in high tolerance endometrial cell RL-95-2 and low tolerance endometrial cell HEC-1-A were detected by real-time quantitative PCR (RT-qPCR), Western blotting and immunofluorescence assay. The invasion and migration of the two kinds of cells were detected by Transwell assay and scratch assay. JAR cells were used to mimic embryos and to detect the migration rate. The expression levels of Galectin-1, epithelial-mesenchymal transition (EMT)-related proteins and WNT/β-catenin signaling pathway-related proteins were analyzed by transfecting Galection-1 siRNA and Galection-1 overexpression vector in the RL-95-2 cells and HEC-1-A cells, respectively. Then the transfected endometrial cells were added with WNT pathway inhibitor DKK1 and activator LiCl respectively, and the changes of EMT-related proteins and the invasion, migration of cells were examined.Results:1) RT-qPCR and Western blotting results showed that Galectin-1 was significantly higher in RL-95-2 than in HEC-1-A ( P=0.020, P=0.030); immunofluorescence experiments showed that Galectin-1 was mainly expressed in the cytoplasm of RL-95-2, while in HEC-1-A cells, Galectin-1 was mainly expressed in the nucleus. 2) The results of cell adhesion assay showed that the adhesion rate of JAR cells to RL-95-2 cells was significantly higher than that to HEC-1-A cells ( P=0.010). 3) After Galectin-1 overexpression, the expression of E-cadherin protein was decreased in the HEC-1-A cells ( P=0.001), and the expressions of N-cadherin and Vimentin were increased ( P=0.003, P=0.023); the exprssioins of β-catenin, WNT4a, WNT5a, and WNT7a were increased ( P=0.025, P=0.004, P=0.005, P=0.001), and the migration ability and invasion ability of HEC-1-A cells were significantly enhanced ( P=0.022, P=0.003). 4) After DKK1 treatment of HEC-1-A cells overexpressing Galectin-1, E-cadherin protein expression was decreased ( P=0.003), N-cadherin and Vimentin protein expressions were increased ( P=0.015, P=0.033), and the migratory ability as well as invasive ability of HEC-1-A cells were significantly increased ( P=0.030, P=0.040). 5) After down-regulation of Galectin-1 expression in RL-95-2 cells, E-cadherin protein expression was increased ( P=0.004), N-cadherin and Vimentin protein expressions were significantly decreased ( P=0.030, P=0.023), and β-catenin, WNT4a, WNT5a, and WNT7a protein expressions were reduced ( P=0.001, P=0.005, P=0.023, P=0.020). 6) After LiCl treatment of RL-95-2 cells with down-regulated Galectin-1 expression, E-cadherin protein expression was increased, and N-cadherin protein and Vimentin protein expressions were decreased compared with LiCl-treated RL-95-2 cells ( P=0.012, P=0.035, P=0.020); RL-95-2 cells migration rate, and invasion number were decreased ( P=0.040, P=0.020). Conclusion:The expression level of Galectin-1 was increased in highly receptivity endometrium compared with low receptivity endometrium. Galectin-1 may regulate the expression of EMT-related proteins through WNT/β-catenin signaling pathway, thus affecting embryo implantation.

[The Involvement of Galectin-1 in Implantation and Pregnancy Maintenance at the Maternal-Fetal Interface].

Impact of Galectin-I on Trophoblast Stem Cell Differentiation and Invasion in in Vitro Implantation Model

A Potential Role of Galectin-1 in Promoting Mouse Trophoblast Stem Cell Differentiation.

Galectin-1 Expression in the Serum and Placenta of Pregnant Women with Fetal Growth Restriction and Its Significance

Research Progress of Galectin-3 Biological Function in Embryo Implantation

Co-Localization Of Galectin-3 And Integrin Beta 3 At Mouse Maternal-Fetal Interface During Early Embryo Implantation

Placental galectins regulate innate and adaptive immune responses in pregnancy

Placental Galectins Are Key Players in Regulating the Maternal Adaptive Immune Response

A unique maternal and placental galectin signature upon SARS-CoV-2 infection suggests galectin-1 as a key alarmin at the maternal–fetal interface

Emergence of Hormonal and Redox Regulation of Galectin-1 in Placental Mammals: Implication in Maternal–fetal Immune Tolerance

Galectin-14 Promotes Trophoblast Migration and Invasion by Upregulating the Expression of MMP-9 and N-Cadherin

Galectin-9 Regulates HTR8/SVneo Function Via JNK Signaling.

Effect of Galectin-1 on the function of endometrial epithelial cells with different receptivity

Modulation of galectin-9 mediated responses in monocytes and T-cells by pregnancy-specific glycoprotein 1

The chimera‐type galectin‐3 is a positive modulator of trophoblast functions with dysregulated expression in gestational diabetes mellitus

Galectin-9 Promotes Human Trophoblast Cell Invasion through Matrix Metalloproteinase-2 and p38 Signaling Pathway

Galectins are critical regulators of cytokine signalling at feto-maternal interface in infection-associated spontaneous preterm birth

Galectin-1-Related Modulation of Trophoblast Endothelial Interactions by Integrins α1 and β1

A Primate Subfamily of Galectins Expressed at the Maternal-Fetal Interface That Promote Immune Cell Death.

Placental Galectins in Cancer: Why We Should Pay More Attention

Fetal growth restriction induced by maternal gal-3 deficiency is associated with altered gut-placenta axis